Health Care · Surgical & Medical Instruments & Apparatus · Nasdaq · CIK 1196298 · no price history on file
Price series unavailable — No prices available for NEPH in [1900-01-01, 2026-07-29]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover3.3d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
NEPH is not in the screener universe.
No return windows available for NEPH.
No risk analytics available for NEPH.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| WEXFORD CAPITAL LP | 3.6M | $11M | — | −0.5% |
| Topline Capital Management, LLC | 581,967 | $2M | — | −5.3% |
| VANGUARD CAPITAL MANAGEMENT LLC | 198,643 | $591,956 | — | new |
| Cornerstone Capital, Inc. | 128,700 | $383,526 | — | new |
| BARD ASSOCIATES INC | 121,202 | $361,182 | — | −0.3% |
| Mesirow Financial Investment Management, Inc. | 120,000 | $357,600 | — | +140.0% |
| MORGAN STANLEY | 110,915 | $330,527 | — | +517.6% |
| RENAISSANCE TECHNOLOGIES LLC | 99,400 | $296,212 | — | −4.2% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for NEPH.
